• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reducing Arterial Stiffness Independently of Blood Pressure: The VaSera Trial.

作者信息

Mills Charlotte E, Govoni Virginia, Faconti Luca, Casagrande Maria-Linda, Morant Steven V, Webb Andrew J, Cruickshank J Kennedy

出版信息

J Am Coll Cardiol. 2017 Sep 26;70(13):1683-1684. doi: 10.1016/j.jacc.2017.07.765.

DOI:10.1016/j.jacc.2017.07.765
PMID:28935045
Abstract
摘要

相似文献

1
Reducing Arterial Stiffness Independently of Blood Pressure: The VaSera Trial.独立于血压降低动脉僵硬度：VaSera试验
J Am Coll Cardiol. 2017 Sep 26;70(13):1683-1684. doi: 10.1016/j.jacc.2017.07.765.
2
A randomised, factorial trial to reduce arterial stiffness independently of blood pressure: Proof of concept? The VaSera trial testing dietary nitrate and spironolactone.一项旨在独立于血压降低动脉僵硬度的随机析因试验：概念验证？VaSera试验对膳食硝酸盐和螺内酯进行测试。
Br J Clin Pharmacol. 2020 May;86(5):891-902. doi: 10.1111/bcp.14194. Epub 2020 Feb 22.
3
Cardiac effects of 6 months' dietary nitrate and spironolactone in patients with hypertension and with/at risk of type 2 diabetes, in the factorial design, double-blind, randomized controlled VaSera trial.在因子设计、双盲、随机对照 VaSera 试验中，研究了 6 个月饮食硝酸盐和螺内酯对高血压伴/有 2 型糖尿病风险患者的心脏影响。
Br J Clin Pharmacol. 2019 Jan;85(1):169-180. doi: 10.1111/bcp.13783. Epub 2018 Nov 13.
4
Spironolactone Reduces Aortic Stiffness in Patients With Resistant Hypertension Independent of Blood Pressure Change.螺内酯可降低高血压患者的主动脉僵硬度，与血压变化无关。
J Am Heart Assoc. 2021 Sep 7;10(17):e019434. doi: 10.1161/JAHA.120.019434. Epub 2021 Aug 28.
5
The usefulness of a single arm cuff oscillometric method (Arteriograph) to assess changes in central aortic blood pressure and arterial stiffness by antihypertensive treatment: results from the Doxazosin-Ramipril Study.采用单臂袖带示波法（动脉血压计）评估降压治疗对中心主动脉血压和动脉僵硬度的影响：多沙唑嗪-雷米普利研究结果
Blood Press. 2018 Apr;27(2):88-98. doi: 10.1080/08037051.2017.1394791. Epub 2017 Oct 26.
6
Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies.耐药性高血压的内分泌和血液动力学变化，以及螺内酯或阿米洛利对血压的反应：PATHWAY-2 机制子研究。
Lancet Diabetes Endocrinol. 2018 Jun;6(6):464-475. doi: 10.1016/S2213-8587(18)30071-8. Epub 2018 Apr 11.
7
Dietary nitrate prevents progression of carotid subclinical atherosclerosis through blood pressure-independent mechanisms in patients with or at risk of type 2 diabetes mellitus.饮食硝酸盐通过独立于血压的机制预防 2 型糖尿病或有 2 型糖尿病风险患者的颈动脉亚临床动脉粥样硬化进展。
Br J Clin Pharmacol. 2021 Dec;87(12):4726-4736. doi: 10.1111/bcp.14897. Epub 2021 May 29.
8
[PATHWAY-2 Study: spironolactone vs placebo, bisoprolol and doxazosin to determine optimal treatment of resistant hypertension. Spironolactone high effective in lowering blood pressure in drug resistant hypertension].[PATHWAY-2研究：螺内酯与安慰剂、比索洛尔和多沙唑嗪对比以确定难治性高血压的最佳治疗方案。螺内酯在降低难治性高血压患者血压方面疗效显著]
Vnitr Lek. 2015 Dec;61(12):1067-71.
9
Spironolactone and doxazosin treatment in patients with resistant hypertension.螺内酯与多沙唑嗪治疗顽固性高血压患者
Rev Esp Cardiol. 2009 Feb;62(2):158-66. doi: 10.1016/s1885-5857(09)71534-8.
10
Effect of oral nitrates on pulse pressure and arterial elasticity in patients aged over 65 years with refractory isolated systolic hypertension: study protocol for a randomized controlled trial.口服硝酸盐对65岁以上难治性单纯收缩期高血压患者脉压和动脉弹性的影响：一项随机对照试验的研究方案
Trials. 2013 Nov 14;14:388. doi: 10.1186/1745-6215-14-388.

引用本文的文献

1
Interventions for the management of concomitant COPD and hypertension: A systematic review.慢性阻塞性肺疾病（COPD）合并高血压的管理干预措施：一项系统评价
J Multimorb Comorb. 2025 Jun 23;15:26335565251341389. doi: 10.1177/26335565251341389. eCollection 2025 Jan-Dec.
2
Effects of short-term dietary nitrate supplementation on exercise and coronary blood flow responses in patients with peripheral artery disease.短期补充膳食硝酸盐对周围动脉疾病患者运动及冠状动脉血流反应的影响。
Front Nutr. 2024 Jul 3;11:1398108. doi: 10.3389/fnut.2024.1398108. eCollection 2024.
3
The association of structural versus load-dependent large artery stiffness mechanisms with cerebrovascular damage and cortical atrophy in humans.
结构与负荷依赖性大动脉僵硬机制与人类脑血管损伤和皮质萎缩的关系。
Geroscience. 2024 Dec;46(6):5587-5597. doi: 10.1007/s11357-024-01254-5. Epub 2024 Jun 20.
4
Oral nitrate supplementation improves cardiovascular risk markers in COPD: ON-BC, a randomised controlled trial.口服硝酸盐补充剂可改善 COPD 的心血管风险标志物：ON-BC，一项随机对照试验。
Eur Respir J. 2024 Feb 1;63(2). doi: 10.1183/13993003.02353-2022. Print 2024 Feb.
5
Cardio-Ankle Vascular Index and Aging: Differences between CAVI and CAVI0.心踝血管指数与衰老：CAVI与CAVI0之间的差异
J Clin Med. 2023 Oct 24;12(21):6726. doi: 10.3390/jcm12216726.
6
Associations between air pollutants and blood pressure in an ethnically diverse cohort of adolescents in London, England.在英格兰伦敦的一个种族多样化的青少年队列中，空气污染物与血压之间的关联。
PLoS One. 2023 Feb 8;18(2):e0279719. doi: 10.1371/journal.pone.0279719. eCollection 2023.
7
Do adrenergic alpha-antagonists increase the risk of poor cardiovascular outcomes? A systematic review and meta-analysis.肾上腺素能 α 拮抗剂是否会增加不良心血管结局的风险？系统评价和荟萃分析。
ESC Heart Fail. 2022 Oct;9(5):2823-2839. doi: 10.1002/ehf2.14012. Epub 2022 Jul 27.
8
A randomised, factorial trial to reduce arterial stiffness independently of blood pressure: Proof of concept? The VaSera trial testing dietary nitrate and spironolactone.一项旨在独立于血压降低动脉僵硬度的随机析因试验：概念验证？VaSera试验对膳食硝酸盐和螺内酯进行测试。
Br J Clin Pharmacol. 2020 May;86(5):891-902. doi: 10.1111/bcp.14194. Epub 2020 Feb 22.
9
Structure-functional changes in eNAMPT at high concentrations mediate mouse and human beta cell dysfunction in type 2 diabetes.高浓度的 eNAMPT 在结构和功能上的变化介导了 2 型糖尿病小鼠和人胰岛β细胞功能障碍。
Diabetologia. 2020 Feb;63(2):313-323. doi: 10.1007/s00125-019-05029-y. Epub 2019 Nov 15.
10
Arterial Stiffness Can Be Modulated by Pressure-Independent Mechanisms in Hypertension.高血压患者的动脉僵硬度可通过压力非依赖性机制进行调节。
J Am Heart Assoc. 2019 Aug 6;8(15):e012601. doi: 10.1161/JAHA.119.012601. Epub 2019 Aug 5.